Published in Cell · View the paper (DOI)
Researchers at University of California, San Diego School of Medicine successfully targeted RNA in living cells using CRISPR-Cas9. This breakthrough may lead to new therapeutic approaches for diseases linked to defective RNA transport, such as autism and cancer.
Coverage from 2 institutions